PET imaging for suspected residual tumour or thoracic recurrence of non-small cell lung cancer after pneumonectomy

Lung Cancer

Volumn 47, Issue 1, 2005, Pages 49-57

  Roberts, Kenneth B ^a   Mac Manus, Michael P ^b,c   Hicks, Rodney J ^b,c   Rischin, Danny ^b,c   Wirth, Andrew ^b,c   Wright, Gavin M ^b,c   Ball, David L ^b,c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PETER MACCALLUM CANCER CENTRE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Metastasis; Non small cell lung cancer; Pneumonectomy; Positron emission tomography; Radiotherapy

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ARTICLE; CANCER CHEMOTHERAPY; CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; HUMAN; LUNG NON SMALL CELL CANCER; LUNG RESECTION; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RADIATION DOSE; RECURRENT CANCER;

CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; DATABASES, FACTUAL; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; PALLIATIVE CARE; PNEUMONECTOMY; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS;

EID: 10444287597     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2004.06.014     Document Type: Article

References (25)

1. D.A. Graham, and J.J. Singer Successful removal of the entire lung for carcinoma of the bronchus J Am. Med. Assoc. 101 1933 1371 1374
2. N. Martini, V.W. Rusch, M.S. Bains, M.G. Kris, R.J. Downey, and B.J. Flehinger Factors influencing ten-year survival in resected stages I to IIIA non-small cell lung cancer J. Thorac. Cardiovasc. Surg. 117 1999 32 36
3. J.D. Slater, N.A. Ellerbroek, H.T. Barkley Jr., C. Mountain, M.J. Oswald, and J.A. Roth Radiation therapy following resection of non-small cell bronchogenic carcinoma Int. J. Radiat. Oncol. Biol. Phys. 20 1991 945 951
4. P. Batra, K. Brown, and R. Steckel Diagnostic imaging techniques in lung carcinoma Am. J. Surg. 153 1987 517 524
5. M.P. Mac Manus, R.J. Hicks, D.L. Ball, V. Kalff, J.P. Matthews, and E. Salminen F-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with non-small cell lung carcinoma: powerful correlation with survival and high impact on treatment Cancer 92 2001 886 895
6. M.P. MacManus, R.J. Hicks, J.P. Matthews, A. Hogg, A.F. McKenzie, and A. Wirth High rate of detection of unsuspected distant metastases by pet in apparent stage III non-small-cell lung cancer: implications for radical radiation therapy Int. J. Radiat. Oncol. Biol. Phys. 50 2001 287 293
7. G.M. Graeber, N.C. Gupta, and G.F. Murray Positron emission tomographic imaging with fluorodeoxyglucose is efficacious in evaluating malignant pulmonary disease J. Thorac. Cardiovasc. Surg. 117 1999 719 727
8. N.C. Gupta, G.M. Graeber, and H.A. Bishop Comparative efficacy of positron emission tomography with FDG and computed tomographic scanning in preoperative staging of non-small cell lung cancer Ann. Surg. 229 1999 286 291
9. S.U. Berlangieri, and A.M. Scott Metabolic staging of lung cancer N. Engl. J. Med. 343 2000 290 292
10. R.M. Pieterman, J.W. van Putten, J.J. Meuzelaar, E.L. Mooyaart, W. Vaalburg, and G.H. Koeter Preoperative staging of non-small-cell lung cancer with positron-emission tomography N. Engl. J. Med. 343 2000 254 261
11. A.J. Poncelet, M. Lonneux, E. Coche, B. Weynand, P. Noirhomme Groupe d'Oncologie Thoracique des Cliniques Saint-Luc PET-FDG scan enhances but does not replace preoperative surgical staging in non-small cell lung cancer Eur. J. Cardio-thorac Surg. 20 2001 468 474
12. P. Goldstraw Treatment of postpneumonectomy empyema: the case for fenestration Thorax 34 1979 740 745
13. H.S. Glazer, D.J. Aronberg, S.S. Sagel, and B. Emami Utility of CT in detecting postpneumonectomy carcinoma recurrence Am. J. Roentgenol. 142 1984 487 494
14. R.T. Heelan, D.M. Panicek, M.E. Burt, J.F. Caravelli, N. Martini, and M. Bains Magnetic resonance imaging of the postpneumonectomy chest: normal and abnormal findings J. Thorac. Imaging 12 1997 200 208
15. R.J. Hicks, V. Kalff, M.P. MacManus, R.E. Ware, A.F. McKenzie, and J.P. Matthews The utility of (18)F-FDG PET for suspected recurrent non-small cell lung cancer after potentially curative therapy: impact on management and prognostic stratification J. Nucl. Med. 42 2001 1605 1613
16. T. Bury, J.L. Corhay, B. Duysinx, F. Daenen, B. Ghaye, and N. Barthelemy Value of FDG-PET in detecting residual or recurrent non-small cell lung cancer Eur. Respir. J. 14 1999 1376 1380
17. J.S. Karp, G. Muehllehner, D.A. MankofF, C.E. Ordonez, J.M. Ollinger, and M.E. Daube-Witherspoon Continuous-slice PENN-PET: a positron tomograph with volume imaging capability J. Nucl. Med. 31 1990 617 627
18. J.S. Karp, and G. Muehllehner Standards for performance measurements of PET scanners: evaluation with the UGM PENN-PET 240H scanner Med. Prog. Technol. 17 1991 173 187
19. F. Benard, R.J. Smith, R. Hustinx, J.S. Karp, and A. Alavi Clinical evaluation of processing techniques for attenuation correction with 137Cs in whole-body PET imaging J. Nucl. Med. 40 1999 1257 1263
20. E. Salminen, and M.P. Mac Manus FDG-PET imaging in the management of non-small-cell lung cancer Ann. Oncol. 13 2002 357 360
21. B.A. Dwamena, S.S. Sonnad, J.O. Angobaldo, and R.L. Wahl Metastases from non-small cell lung cancer: mediastinal staging in the 1990s - meta-analytic comparison of PET and CT Radiology 213 1999 530 536
22. H. van Tinteren, O.S. Hoekstra, E.F. Smit, J.H. van den Bergh, A.J. Schreurs, and R.A. Stallaert Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial Lancet 359 2002 1388 1393
23. A.M. Lever, D. Henderson, D.A. Ellis, P.A. Corris, and J.J. Gilmartin Radiation fibrosis mimicking local recurrence in small cell carcinoma of the bronchus Br. J. Radiol. 57 1984 178 180
24. M.P. Mac Manus, R.J. Hicks, J.P. Matthews, A. McKenzie, D. Rischin, and E.K. Salminen Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small-cell lung cancer J. Clin. Oncol. 21 2003 1285 1292
25. M.P. Mac Manus, K. Wong, R.J. Hicks, J.P. Matthews, A. Wirth, and D.L. Ball Early mortality after radical radiotherapy for non-small-cell lung cancer: comparison of PET-staged and conventionally staged cohorts treated at a large tertiary referral center Int. J. Radiat. Oncol. Biol. Phys. 52 2002 351 361